Abbott India Limited (NSE: ABBOTINDIA)
India
· Delayed Price · Currency is INR
27,719
+604 (2.23%)
Nov 22, 2024, 3:29 PM IST
Abbott India Revenue
Abbott India had revenue of 16.33B INR in the quarter ending September 30, 2024, with 9.27% growth. This brings the company's revenue in the last twelve months to 60.66B, up 7.58% year-over-year. In the fiscal year ending March 31, 2024, Abbott India had annual revenue of 58.49B with 9.35% growth.
Revenue (ttm)
60.66B
Revenue Growth
+7.58%
P/S Ratio
n/a
Revenue / Employee
15.90M
Employees
3,814
Market Cap
588.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 58.49B | 5.00B | 9.35% |
Mar 31, 2023 | 53.49B | 4.35B | 8.86% |
Mar 31, 2022 | 49.13B | 6.03B | 14.00% |
Mar 31, 2021 | 43.10B | 2.17B | 5.30% |
Mar 31, 2020 | 40.93B | 4.15B | 11.27% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAbbott India News
- 16 days ago - Abbott India shares fall nearly 4% following Q2 results - Business Upturn
- 16 days ago - Abbott India Q2 FY25 Results: Revenue up 9.3% YoY to ₹1,632.67 crore, Net Profit rises 14.6% YoY - Business Upturn
- 4 weeks ago - Pharma stocks today: Gland Pharma rises 1.53%, Aurobindo Pharma up 1.38%, while Natco Pharma falls 1.40%, and Laurus Labs down 1.41% - Business Upturn
- 5 weeks ago - Pharma Stocks Update: Check out how Cipla, Lupin, Abbott India, Divi’s Lab, Zydus Life, Dr Reddy’s Lab are performing today - Business Upturn
- 2 months ago - Abbott India partners with Takeda Pharmaceuticals to launch Vonefi - Business Upturn